Syntekabio to Showcase its AI Drug Discovery Tech at Bio-IT World Expo
Syntekabio, a global artificial intelligence (AI) drug discovery pioneer, has announced its participation at the upcoming Bio-IT World Conference & Expo.
Drug Discovery & Development | 12/04/2024 | By Aishwarya | 548
TPM-1116 represents a new chemical series of OX2R agonists with the potential for a best-in-class clinical profile.
Drug Discovery & Development | 11/04/2024 | By Manvi | 760
Sartorius and TheWell Bioscience to Enable More Accurate Predictions in Drug Discovery
Sartorius has teamed up with TheWell Bioscience on the further development of hydrogels and bioinks tailored to produce 3D advanced cell models for drug discovery workflows.
Drug Discovery & Development | 10/04/2024 | By Aishwarya | 330
Lupin Rolls Out First Generic Version of Oracea
Lupin has unveiled the first generic version of Oracea (Doxycycline Capsules, 40 mg), in the United States.
Drug Discovery & Development | 10/04/2024 | By Aishwarya | 621
AustinPx Invests in Pharmaceutics and Manufacturing Capabilities to Boost Drug Development
The latest investments enhance AustinPx’s early phase development and manufacturing capabilities by enabling faster timelines, improved stability, and reduced risk.
Drug Discovery & Development | 09/04/2024 | By Manvi | 612
Dr Reddy's, Bayer to Market Second Brand of Vericiguat in India
Dr Reddy’s Laboratories has joined forces with Bayer to introduce a second brand of Vericiguat, a medication for chronic heart failure, to the Indian market.
Drug Discovery & Development | 08/04/2024 | By Aishwarya | 1469
Acumen Pharmaceuticals Join Hands with Lonza to Bolster Sabirnetug Production
Acumen Pharmaceuticals has signed a partnership agreement with Lonza, a global partner to the pharmaceutical, biotech, and nutraceutical markets.
Drug Discovery & Development | 05/04/2024 | By Aishwarya | 712
Aurigene Rolls Out AI and ML Assisted Drug Discovery Platform
Aurigene Pharmaceutical Services Ltd., a subsidiary of Dr Reddy’s Laboratories, has launched Aurigene. AI, an innovative platform integrating artificial intelligence.
Drug Discovery & Development | 05/04/2024 | By Aishwarya | 996
Asahi Kasei Medical and AW Technologies Sign Agreement for TrachFlush in Japan
AW Technologies is currently in the process of medical device registration of the TrachFlush in Japan, with market launch targeted in fiscal 2024.
Drug Discovery & Development | 03/04/2024 | By Manvi | 680
Teva UK and Closed Loop Medicine Collaborates to Advance Development of Personalised Medicines
Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicines.
Drug Discovery & Development | 26/03/2024 | By Manvi | 249
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy